KU Leuven vaccine candidate protects against COVID-19 and yellow fever

Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against COVID-19 based on the yellow fever vaccine, which as a result also works against yellow fever. Results published today in Nature show that the vaccine protects hamsters from infection with the SARS-CoV-2 coronavirus after a single dose. The vaccine is also effective in monkeys. The team is currently preparing for clinical trials.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news